The UK will prioritise giving more people the first dose of the CCP virus vaccine over ensuring people receive the second dose, according to new advice published on Wednesday. The new recommendation by the Joint Committee on Vaccination and Immunisation (JCVI) came as part of the advice on the Oxford/AstraZeneca COVID-19 vaccine, which was approved on the same day. “Evidence from Phase 3 trials indicate high levels of protection against serious disease and death from around 2 weeks after the first dose,” the JCVI said. Therefore, “the committee recommends that vaccinating more people with the first dose is prioritised above offering others their second dose.” Professor Wei Shen Lim, COVID-19 chair for JCVI, said that this is to maximise the benefits in the current situation and save more lives. The committee said that both the Oxford/AstraZeneca and the Pfizer/BioNTech vaccines are “acceptably safe and effective,” and that “high levels of protection …